Havrix Monodose Vaccine, Hepatitis A Vaccine (Inactivated, adsorbed) Susp for Inj 1440ELU/ml Malta - English - Medicines Authority

havrix monodose vaccine, hepatitis a vaccine (inactivated, adsorbed) susp for inj 1440elu/ml

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - hepatitis a, virus, inactivated, elisa - suspension for injection in pre-filled syringe - hepatitis a virus (inactivated) 1440 elisa unit/dose - vaccines

Havrix Junior Monodose Vaccine, Hepatitis A Vaccine(Inactivated Absorbed) Susp for Inj 720ELU/0.5ml Malta - English - Medicines Authority

havrix junior monodose vaccine, hepatitis a vaccine(inactivated absorbed) susp for inj 720elu/0.5ml

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - hepatitis a, virus, inactivated, elisa - suspension for injection in pre-filled syringe - hepatitis a virus (inactivated) 720 elisa unit/dose - vaccines

INFANRIX-IPV+Hib powder and suspension for suspension for injection. Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed) Malta - English - Medicines Authority

infanrix-ipv+hib powder and suspension for suspension for injection. diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis filamentous, haemagglutinin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate, tetanus toxoid - powder and suspension for suspension for injection - pertactin 8 µg pertussis filamentous haemagglutinin 25 µg pertussis toxoid 25 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu/0.5ml poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu/0.5ml poliovirus (inactivated) type 3 (saukett strain) 32 dagu/0.5ml diphtheria toxoid haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg tetanus toxoid - vaccines

Inactivated Mycoplasma hyopneumoniae strain J Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

inactivated mycoplasma hyopneumoniae strain j

intervet australia pty limited - inactivated mycoplasma hyopneumoniae strain j - unknown - inactivated mycoplasma hyopneumoniae strain j vaccine - general active 0.0 - immunotherapy

POULVAC NEWCASTLE IK VACCINE (INACTIVATED) Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

poulvac newcastle ik vaccine (inactivated)

zoetis australia pty ltd - inactivated newcastle disease virus antigen - parenteral liquid/solution/suspension - inactivated newcastle disease virus antigen vaccine-viral active 0.0 eid/50 - immunotherapy - poultry - see label | chicken - newcastle disease

Coxevac European Union - English - EMA (European Medicines Agency)

coxevac

ceva santé animale - inactivated coxiella burnetii vaccine, strain nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus., onset of immunity: not established., duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta., onset of immunity: not established., duration of immunity: one year after completion of the primary vaccination course.

Eravac European Union - English - EMA (European Medicines Agency)

eravac

laboratorios hipra, s.a. - inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strainv-1037 - inactivated viral vaccines - rabbits - for active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (rhdv2)

Suvaxyn Circo+MH RTU European Union - English - EMA (European Medicines Agency)

suvaxyn circo+mh rtu

zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inactivated viral and inactivated bacterial vaccines - pigs - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.for active immunisation of pigs over the age of 3 weeks against mycoplasma hyopneumoniae to reduce lung lesions caused by infection with m. hyopneumoniae.

Zulvac SBV European Union - English - EMA (European Medicines Agency)

zulvac sbv

zoetis belgium sa - inactivated schmallenberg virus, strain bh80/11-4 - immunologicals for bovidae, inactivated viral vaccines - cattle; sheep - for active immunisation of cattle and sheep from 3.5 months of age to prevent viraemia associated with infection by schmallenberg virus.

Respiporc FLUpan H1N1 European Union - English - EMA (European Medicines Agency)

respiporc flupan h1n1

idt biologika gmbh - inactivated influenza a virus/human - immunologicals, inactivated viral vaccines for pigs, porcine influenza virus - pigs - active immunisation of pigs from the age of 8 weeks onwards against pandemic h1n1 porcine influenza virus to reduce viral lung load and viral excretion.